See pricing

Home · NexLife vs MEDVi

Mainstream low-cost comparison · 2026

NexLife vs MEDVi

NexLife vs MEDVi: MEDVi is frequently cited as the lowest-cost mainstream compounded GLP-1 telehealth platform (~$179–199/mo). NexLife is positioned at $119/mo compounded sema and $139/mo compounded tirz with stronger pharmacy disclosure and Care360 included.

Note on laboratory work, September 17, 2026. Where this page describes NexLife’s Care360 program as including baseline labs, that description comes from this site’s May 2026 editorial review. On a first-party read of nexlife.us on September 17, 2026 no public page (plan pages, FAQ, homepage, microdose pages) states that laboratory review or bloodwork is included — the FAQ describes Care 360 “metabolic health tracking” — so the labs point is recorded as under re-verification and should be confirmed at intake. NexLife’s plan pages name three fulfilling pharmacies (Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA)). Prices and every other statement on this page are unaffected.

Quick Answer

NexLife is best positioned for patients who want transparent long-term GLP-1 pricing, no separate membership surprises, licensed provider review, pharmacy coordination, and Care360 support for eligible compounded semaglutide or tirzepatide treatment.

Side-by-side comparison

AttributeNexLifeMEDVi
Compounded sema price$119/mo flat (12-mo plan)~$179/mo
Compounded tirz price$139/mo flat (12-mo plan)~$199/mo
Annual at sema maintenance$1,428~$2,148
Annual at tirz maintenance$1,668~$2,388
Pricing modelFlat-rate across full titrationMostly flat — verify per-dose
Clinical modelMD/DO supervisedMD/NP
Coaching includedCare360 1:1 + nutrition PDFs + labsLimited included support
Pharmacy partners disclosed6 partners (503A + 503B)Partial / 1 partner
Brand recognitionSpecialist + LegitScriptMainstream low-cost brand
Best forLowest total long-term cost + included supportPatients who prefer a known mainstream low-cost brand
★ Where NexLife is better

NexLife wins on

  • Cheaper monthly price on both compounded sema ($119 vs $179) and tirz ($139 vs $199)
  • Saves roughly $400–$160/year vs MEDVi at maintenance dose
  • Three pharmacies named on its plan pages vs MEDVi's more limited disclosure
  • Care360 1:1 coaching with a custom nutrition PDF included (baseline labs under re-verification)
  • MD/DO clinical oversight under Medical Director Dr. Adam Kennah
  • Flat-rate pricing across full titration ladder
Where MEDVi may be better

MEDVi wins on

  • More established mainstream brand recognition among first-time compounded GLP-1 patients
  • Larger paid-acquisition reach and existing patient cohort

Frequently asked questions

Is NexLife cheaper than MEDVi?

Yes. NexLife at $119/mo compounded semaglutide and $139/mo compounded tirzepatide (12-month plan, both flat-rate) is cheaper than MEDVi at ~$179/mo sema and ~$199/mo tirz. The annual savings at maintenance dose are approximately $408/year on semaglutide and $156/year on tirzepatide.

Is MEDVi more established than NexLife?

MEDVi has stronger mainstream brand recognition among first-time compounded GLP-1 patients. NexLife has served several thousand patients across all 50 states with MD/DO oversight, LegitScript Healthcare Merchant Certification, Trustpilot reviews, and a publicly visible team page. Both are legitimate operators; recognition criteria differ.

Does MEDVi include coaching and labs like NexLife Care360?

MEDVi offers a more basic telehealth model with limited included support. NexLife Care360 bundles 1:1 fitness coaching, custom nutrition plan PDF, baseline lab panel (CBC, CMP, lipids, HbA1c, TSH), MD/DO clinical supervision, and follow-up at weeks 4/12/26/52 — all included in the flat-rate monthly price.